GTG 5.56% 0.9¢ genetic technologies limited

GTG Market Cap

  1. 102 Posts.
    lightbulb Created with Sketch. 1
    OK, maybe I'm missing something .....

    The current Market Cap of GTG is $56M with a Share Price of $0.050.

    Kentgrove Capital Growth Fund are putting $24M into GTG. According to GTG's Quarterly Activities Report - 31 December 2014, GTG have $1.25M in Cash at the end of the December 2014 Quarter. Therefore, that's $25M in Cash. You would imagine that GTG has some value in their Assets in their business (e.g. Instruments, Equipment, etc).

    Does that mean that the difference (i.e. approximately $30M less their Asset value) is the value placed on GTG's IP, including BREVAGenplus?

    That sounds incredibly low to me when it used to have a Market Cap of well over $100M when it had a lot less Cash and when it had less access to distribution of BREVAGen / BREVAGenplus in the U.S.!

    Your thoughts?

    By the way, as of now the share price has just broken US$9.40 (up over 50% today)!
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Mkt cap $18.50M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $3.18K 370K

Buyers (Bids)

No. Vol. Price($)
9 3963744 0.8¢

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1202727 4
Last update - 15.50pm 18/01/2019 (20 minute delay) ?
-0.00 ( 11.1 %)
Open High   Low Volume
0.8¢ 0.8¢   0.8¢ 100000
Last updated 13.16pm 18/01/2019 (live) ?
GTG (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.